We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DRR:ASXDeterra Royalties Ltd Analysis

Data as of 2026-06-21 - not real-time

A$4.43

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Deterra Royalties is trading below its recent moving averages, with price comfortably above the 200‑day trend line, indicating a generally bullish backdrop. The stock benefits from a strong dividend yield and a payout ratio that suggests current earnings can comfortably fund the distribution, while free cash flow remains robust despite a high debt load. Technical signals are mixed: the MACD histogram is marginally negative and the RSI hovers near neutral, but the overall trend remains bullish and volume is stable. Valuation models point to a modest upside relative to the current price, and analyst consensus leans toward a buy recommendation, reinforcing the case for investors seeking income and exposure to a diversified royalty portfolio.
The primary risks stem from the company's elevated leverage and the cyclical nature of the basic materials sector, which could pressure earnings if commodity prices soften. However, the low beta indicates limited price volatility relative to the market, and the extensive geographic footprint spreads country‑specific regulatory and currency exposures. In summary, the stock offers a balanced mix of income, modest capital appreciation potential, and diversified royalty assets, making it attractive for investors with a medium‑to‑long‑term horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near identified support level
  • mixed MACD signal with slight bearish tilt
  • high dividend yield providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • modest upside to fair‑value estimate
  • analyst consensus of buy and target price above current level
  • sustainable dividend supporting total return

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • diversified royalty portfolio across multiple commodities and jurisdictions
  • strong free cash flow generation to service debt and fund dividends
  • low beta indicating limited market volatility over extended horizons

Key Metrics & Analysis

Financial Health

Revenue Growth8.10%
Profit Margin65.67%
P/E Ratio13.0
ROE149.19%
ROA36.60%
Debt/Equity112.65
P/B Ratio16.9
Op. Cash FlowA$172.6M
Free Cash FlowA$151.6M

Technical Analysis

TrendBullish
RSI48.3
SupportA$4.26
ResistanceA$4.74
MA 20A$4.50
MA 50A$4.36
MA 200A$4.19
MACDBearish
VolumeStable
Fear & Greed Index91.46

Valuation

Fair ValueA$5.03
Target PriceA$4.65
Upside/Downside4.87%
GradeUndervalued
TypeBlend
Dividend Yield5.60%

Risk Assessment

Beta0.54
Volatility22.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.